← Eichor
Study identifier: NCT06185621 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Aspirin on Recurrent Acute Pancreatitis

Condition: Recurrent Acute Pancreatitis · Prevention · Aspirin  ·  Sponsor: Air Force Military Medical University, China

PhaseNA
Planned participants23
Who can joinAll sexes, 14 Years to 80 Years
Healthy volunteersNo

About this study

Recurrent acute pancreatitis (RAP) was defined as two or more occurrences of acute pancreatitis, which was associated with higher percentages of morbidities and mortalities, lower patients' life quality and increased health-care costs. Current interventions, including cholecystectomy and abstain from drinking were reported to be effective methods for preventing the recurrences of biliary and alcoholic etiologies, respectively. However, there were no effective preventions for other etiologies, such as idiopathic etiologies. Non-steroid anti-inflammatory drugs (NSAIDs), including indomethacin, diclofenac and aspirin could inhibiting the inflammatory cascade of pancreatitis. In this study, we aimed at exploring the effects of 100mg aspirin on reducing the occurrences of recurrent acute pancreatitis.

This description comes directly from the study's public registry record.

Talk to the study team

Yanglin Pan, MD  ·  +8613991811225  ·  yanglinpan@hotmail.com

Xiaoyu Kang, MD  ·  +8615291680602  ·  kangxiaoyu@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Air Force Military Medical University, ChinaXi'an, Shaanxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06185621